The Markey Cancer Center (MCC) Clinical Research Organization coordinates and facilitates clinical cancer trials at the MCC. The major goals of the clinical trials office are to provide support of the clinical trial process, including implementing and regulating trials, provide a centralized clinical trial database, and integrate with the following: investigational pharmacy support, financial accounting, data safety monitoring, and quality assurance. This shared resource also assists physician investigators in the design and subsequent conduct of clinical trials through its support of the Investigator Initiated Trial Protocol Development Unit. It performs all regulatory reporting and quality assurance needed to comply with good clinical practice in the performance of clinical trials.
View Active Cancer Trials.
Are you thinking about starting a clinical trial? Download the Clinical Research fee structure (PDF, 92 KB) to help budget accurately.
The Markey Cancer Center is a full-member institute in multiple cooperative clinical trials groups of the National Cancer Institute, including:
- Alliance (Cancer and Leukemia Group B [CALGB], American College of Surgeons Oncology Group [ACOSOG], and North Central Cancer Treatment Group [NCCTG])
- Eastern Cooperative Oncology Group (ECOG)
- NRG Oncology (National Surgical Adjuvant Breast and Bowel Project [NSABP], the Radiation Therapy Oncology Group [RTOG], and the Gynecologic Oncology Group [GOG])
- Pediatric Oncology Group
- Southwest Oncology Group
- Clinical Trial Engagement Network
Download a list (PDF, 41 KB) of the committee members who serve on Markey's Data Safety and Monitoring Committee, Protocol Review and Monitoring Committee, and Audit Committee.